Bevacizumab in Ovarian Cancer Extends Overall SurvivalBevacizumab in Ovarian Cancer Extends Overall Survival

Adding the antiangionic agent to combination chemotherapy shows a clinically meaningful improvement in overall survival compared with standard chemotherapy alone. Medscape Medical News
Source: Medscape Hematology-Oncology Headlines - Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news